Intracavernous injection as an option for aging men with erectile dysfunction.
Sexuality remains a vital aspect of life in spite of aging. Advances in impotence research and increased knowledge of the pathophysiology of erection have completely changed the treatment of erectile dysfunction. Before oral therapy, intracavernous injection was considered as the first-line therapy for impotent patients. However, the new simple oral treatment raises the question as to whether intracavernous injection therapy is still a useful tool for treatment of aging men with erectile dysfunction. The efficacy and safety of oral therapy and intracavernous injection are reviewed.
Wespes
E
E
Department of Urology, CHU de Charleroi, Boulevard Zöe Drion Drion, 1 6000 Charleroi, Belgium.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000375:Aging / Q000473:pathology*; D000527:Alprostadil / Q000008:administration & dosage* / Q000009:adverse effects; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D010413:Penis / Q000187:drug effects / Q000503:physiopathology; D010879:Piperazines / Q000008:administration & dosage* / Q000009:adverse effects; D011453:Prostaglandins / Q000008:administration & dosage; D011687:Purines; D019529:Sexuality; D000068677:Sildenafil Citrate; D013450:Sulfones; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000009:adverse effects
D010879:Piperazines; D011453:Prostaglandins; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate; D000527:Alprostadil